Differential diagnostics of interstitial lung diseases

Czech version

Authors: Martina Šterclová
Authors‘ workplace: Pneumologická klinika 1. LFK UK a FTN, Praha ; Pneumologická klinika 2. LF UK a FN Motol, Praha
Published in: Vnitř Lék 2023; 69(3): 193-197
Category: Differential Diagnosis Column or What You Can Be Asked at a Postgraduate Certification Exam
doi: https://doi.org/10.36290/vnl.2023.033

Overview

Interstitial lung diseases very often do not only affect the lung tissue, but are part of multisystem diseases. Awareness of their classification and differential diagnosis therefore does not belong only to respiratory departments, but shall be acknowledged by all specialisations. It is obvious that the approach to a patient with life-threatening disease or acute onset of symptoms differently then patients with slow disease onset or „accidentally“ detected lung abnormalities. The presented manuscript brings a differential diagnostic approach to facilitate orientation in the field of interstitial ling diseases.

Keywords:

classification – Interstitial lung diseases – differential diagnosis – examination methods

Sources

1. Aktuální a pravidelně aktualizované doporučené postupy pro diagnostiku a léčbu řady IPP, stejně jako aktuální a aktualizovaný seznam Center pro diagnostiku a léčbu IPP jsou k dispozici na www.pneumologie.cz – Guidelines | Pneumologie (navštíveno 14. 1. 2023) a Sekce pro intersticiální plicní procesy | Pneumologie (navštíveno 14. 1. 2023)

2. Matěj R, Polák J, Vašáková M. Intersticiální plicní procesy (2. vydání). Maxdorf: Praha 2016. ISBN 978-80-7345-488-3

3. Kočová E, Koziar Vašáková M (ed.) et al. HRCT u intersticiálních plicních procesů v instruktivních kazuistikách (3. vydání). Maxdorf: Praha 2021. ISBN 978-80-7345-712-9

4. Šterclová M et al. Progredující fibrotizující intersticiální plicní procesy. Maxdorf: Praha 2022. ISBN 978-7345-741-9.

Labels

Diabetology Endocrinology Internal medicine

Hlavní téma – Multimorbidita ve vnitřním lékařství

Perioperative care about a patient with multimorbidity

Multimorbidity in nephrotic syndrome

Critical care for multimorbid patients

Clinical assessment and management of patients with multimorbidity

JAK inhibition in the treatment of inflammatory rheumatic diseases

Effect of sodium-glucose co-transporter-2 inhibitor empagliflozin on disease progression in a patient with heart failure and preserved ejection fraction

News in gastroenterology, hepatology and digestive endoscopy

Article was published in

Internal Medicine

2023 Issue 3